Clinical Trials on 癌症和/或血液恶性肿瘤 in Australia
总计3754个结果
-
Antengene Therapeutics LimitedBristol-Myers Squibb招聘中
-
Melbourne HealthPeter MacCallum Cancer Centre, Australia; Western Sydney Local Health District; Walter and Eliza... 和其他合作者邀请报名
-
Medical University of Vienna完全的
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin Health完全的
-
Bayside HealthThe Alfred; The Leukaemia Foundation of Victoria未知
-
The University of Western AustraliaJohns Hopkins University; Vanderbilt University Medical Center; Guy's and St Thomas' NHS Foundation... 和其他合作者招聘中
-
Senti Biosciences招聘中反洗钱/材料数据表 | CD33 表达血液恶性肿瘤 | FLT3 表达血液恶性肿瘤美国, 澳大利亚
-
Centre Hospitalier Universitaire Vaudois未知
-
The Netherlands Cancer InstituteBristol-Myers Squibb主动,不招人
-
AstraZenecaParexel主动,不招人
-
Asbestos Diseases Research FoundationEnGeneIC Limited完全的
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy Centre完全的
-
Hummingbird BioscienceMerck KGaA, Darmstadt, Germany招聘中
-
Kite, A Gilead Company邀请报名
-
MapKure, LLC招聘中大肠癌 | 胰腺导管癌 | 晚期或转移性 RAS 突变结直肠癌和胰腺导管癌澳大利亚, 美国
-
R-PharmGlaxoSmithKline终止
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLC招聘中局部晚期或转移性 HER2 表达癌症澳大利亚, 西班牙, 法国, 葡萄牙
-
University of SydneyUniversity of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient Registry; Northern...招聘中
-
PfizerHospira, now a wholly owned subsidiary of Pfizer完全的
-
Vyne Therapeutics Inc.完全的
-
Peter MacCallum Cancer Centre, AustraliaNational Health and Medical Research Council, Australia; University of Melbourne招聘中
-
Bayer终止血友病 A 和 B澳大利亚, 英国, 台湾, 日本, 大韩民国, 奥地利, 保加利亚, 匈牙利, 意大利, 法国, 新西兰
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research Group完全的